300642 Stock Overview
Researches and develops, manufactures, and distributes IVDs in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Tellgen Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.15 |
| 52 Week High | CN¥19.82 |
| 52 Week Low | CN¥9.94 |
| Beta | 0.36 |
| 11 Month Change | 25.67% |
| 3 Month Change | 0.71% |
| 1 Year Change | -27.14% |
| 33 Year Change | -53.69% |
| 5 Year Change | -36.23% |
| Change since IPO | -26.50% |
Recent News & Updates
Shareholder Returns
| 300642 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 22.2% | -0.8% | -0.3% |
| 1Y | -27.1% | -14.6% | -18.1% |
Return vs Industry: 300642 underperformed the CN Medical Equipment industry which returned -16.2% over the past year.
Return vs Market: 300642 underperformed the CN Market which returned -19% over the past year.
Price Volatility
| 300642 volatility | |
|---|---|
| 300642 Average Weekly Movement | 8.1% |
| Medical Equipment Industry Average Movement | 5.1% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in CN Market | 8.9% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 300642 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300642's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 574 | Jian Er Yao | www.tellgen.com |
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; cardiovascular and inflammation; biochemistry kits; DNA methylation testing kits; and molecular detection of COVID-19 and others. It also provides diagnostic reagents/testing instruments and assembly lines.
Tellgen Corporation Fundamentals Summary
| 300642 fundamental statistics | |
|---|---|
| Market cap | CN¥2.29b |
| Earnings (TTM) | CN¥73.79m |
| Revenue (TTM) | CN¥514.04m |
31.1x
P/E Ratio4.5x
P/S RatioIs 300642 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300642 income statement (TTM) | |
|---|---|
| Revenue | CN¥514.04m |
| Cost of Revenue | CN¥173.85m |
| Gross Profit | CN¥340.18m |
| Other Expenses | CN¥266.40m |
| Earnings | CN¥73.79m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 27, 2024
| Earnings per share (EPS) | 0.46 |
| Gross Margin | 66.18% |
| Net Profit Margin | 14.35% |
| Debt/Equity Ratio | 0.4% |
How did 300642 perform over the long term?
See historical performance and comparison